NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8800
-0.0091 (-1.02%)
At close: Sep 15, 2025, 4:00 PM EDT
0.8999
+0.0199 (2.26%)
After-hours: Sep 15, 2025, 7:57 PM EDT
NMTC Market Cap
NMTC has a market cap or net worth of $44.00 million as of September 15, 2025. Its market cap has increased by 80.30% in one year.
Market Cap
44.00M
Enterprise Value
36.26M
1-Year Change
80.30%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since August 1, 2017, NMTC's market cap has increased from $31.46M to $44.00M, an increase of 39.86%. That is a compound annual growth rate of 4.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 44.45M | 74.52% |
| Dec 31, 2024 | 25.47M | -32.72% |
| Dec 29, 2023 | 37.86M | 94.30% |
| Dec 30, 2022 | 19.49M | -36.27% |
| Dec 31, 2021 | 30.57M | -15.31% |
| Dec 31, 2020 | 36.10M | 10.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |